Pharmaceutical companies vigorously build production bases, which will be a great benefit to pharmaceutical machine companies

[ Market Analysis of Chemical Machinery Equipment Network ] Since the beginning of this year, in order to further expand the company's production capacity and improve market competitiveness, more and more domestic pharmaceutical companies have begun to announce the construction of production bases one after another
.
For example, on June 9, WuXi AppTec’s subsidiary Hequan Pharmaceutical announced that the company will build an integrated production base containing APIs and preparations in Middleton, Delaware, USA, to further expand the platform’s capabilities and scale
.
It is understood that the base covers an area of ​​about 756,000 square meters and is expected to be officially put into operation in 2024
.

On June 7, the foundation stone laying ceremony was also held for the intelligent manufacturing base of traditional Chinese medicine formula granules in Shanghe County of Hongri Pharmaceutical, which broke ground
.
It is understood that at the beginning of this year, Hongri Pharmaceutical signed a contract with the People's Government of Shanghe County, Jinan City, Shandong Province, and planned to invest 750 million yuan to establish an intelligent manufacturing base for 10,000-ton Chinese medicine formula granules
.
It is worth mentioning that, in addition, it has also established 7 automatic production bases of traditional Chinese medicine formula granules, and is vigorously entering the market of traditional Chinese medicine formula granules
.

 

　　In addition to the above companies, Antengene, BeiGene, WuXi Biologics, etc.
are also building and acquiring production bases to further adjust the industrial structure, optimize the industrial layout, and better realize the sharing of public systems, comprehensive utilization of resources, and pollution.
Centralized governance; and the implementation of green production standards and industry supervision to further improve industrial concentration and help enterprises achieve high-quality development
.

 

　　The analysis believes that in order to meet the continuous improvement of industrial demand in the future, more pharmaceutical companies will also choose to build and acquire production bases to expand the company's production capacity and improve market competitiveness
.
In this context, the industry expects that pharmaceutical equipment companies closely related to drug production and the pharmaceutical industry will also usher in more opportunities
.
The analysis believes that as more and more companies start to build production bases, they are conducting research and development on related pharmaceuticals
.
The demand for production equipment will naturally continue to increase
.

 

　　Therefore, in order to meet the continuous expansion of pharmaceutical companies' demand for new equipment, pharmaceutical equipment companies should be more proactive in seizing opportunities
.
It is reported that in order to help pharmaceutical companies improve workshop productivity and efficiency, many pharmaceutical equipment companies have begun to act
.
If any company has been accelerating the construction of important projects since last year, the entire project is scheduled to be completed in the first half of 2022
.
The relevant person in charge of the company said that measures are currently being taken to speed up the progress of the project, so as to better meet China's demand for related pharmaceutical production equipment under the current situation
.

 

　　In addition, some companies have built glass tube factories in Jinyun in order to meet the needs of Chinese pharmaceutical companies in glass pharmaceutical packaging
.
Equipped with professional quality inspection technology, the factory is expected to play a key role in quickly realizing local mass production of high-quality glass tubes
.
It is worth mentioning that the new factory consists of two kilns, one of which has been put into operation in November 2020, with a production capacity of 10,000 tons/year.
The new kiln is expected to be fired in September this year, which also means The capacity of the new plant can reach 20,000 tons/year by the fourth quarter
.

 

　　From the perspective of pharmaceutical companies, pharmaceutical equipment is an indispensable tool and equipment for pharmaceutical production, as well as the "heart" and "engine" of the pharmaceutical industry
.
Therefore, as pharmaceutical companies continue to expand production capacity, their demand for high-efficiency and energy-saving pharmaceutical equipment will also continue to increase
.
However, it is worth noting that the performance, functions, and precise control accuracy of pharmaceutical equipment will directly affect the quality of pharmaceuticals.
Therefore, in order to better promote the further development of pharmaceutical companies and expand production capacity, the industry believes that the pharmaceutical equipment industry also needs continuous innovation.
Thus, the introduction of higher quality equipment can further meet the market demand
.

 

　　It is understood that in recent years, with the continuous introduction of favorable national policies and the efforts of the pharmaceutical equipment industry, in fact, China's pharmaceutical equipment technology has been continuously achieving breakthroughs.
Among them, the pharmaceutical equipment industry represented by Chutian Technology, Tofflon, and Canaan Technology , it is taking the responsibility of realizing domestic substitution of imports
.
At present, some products and equipment have performed very well in the industry; for the pharmaceutical industry, this also brings stronger equipment support for pharmaceutical companies and the entire pharmaceutical business
.

 

　　Original title: Pharmaceutical companies vigorously build production bases, which will be a great benefit to pharmaceutical machine companies